Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion type Assertion NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_head.
- NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion wasGeneratedBy ECO_0000203 NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_provenance.
- NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion wasDerivedFrom befree-2016 NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_provenance.
- NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion SIO_000772 14533014 NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_provenance.
- NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion evidence source_evidence_literature NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_provenance.
- NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_assertion description "[Because WNT2 up-regulation leads to carcinogenesis through activation of the WNT-beta-catenin pathway, WNT2 specific antagonist might be applied for chemoprevention or treatment of gastrointestinal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416113.RAGzwvcUKrYnpI1-_HNkNNcnxxAJxiY6eUkY4b3j_GcpE130_provenance.